Sr. Manager, Quality Assurance
Boost your chances before you apply.
Alnylam Pharmaceuticals
US
Summary
The role involves designing and executing real-world evidence studies and economic models to support the value proposition of pharmaceutical products. You will collaborate with cross-functional teams to generate insights from healthcare data and contribute to scientific publications.
Job Description
Name of Employer: Alnylam US, Inc.
Position Title: Director, Value & Evidence Strategy
Job Location: 675 West Kendall Street, Flr 6, Cambridge, MA 02142.
100% telecommuting role. Reports to company headquarters in Cambridge, MA.
Can work remotely or telecommute.
Salary: $226,600.00 - $280,700.00/year
Hours: Monday – Friday, 9:00 am to 5:00 pm
Summary of Duties:
Support real world data analyses across multiple late stage and marketed assets, including design and execution of the following types of analyses: treatment patterns and drug utilization, resource utilization, adherence and persistency, survival, cost-effectiveness, comparative effectiveness, burden of disease, and indirect treatment comparisons (e.g., network meta-analysis, quantitative bias assessment). Collaborate with cross-functional colleagues (Epidemiology, Biostatistics, HEOR, Medical Directors, Market Access) in delivering analytics and insights using medical claims and electronic health records. Develop payer-facing analytic tools and models. Develop evidence to support key value messages. This position supports the design and conduct of real-world data (RWD) analyses focused on pharmaceutical and biotechnology products that are in late-stage clinical development (Phase III or Phase IV) or have already received regulatory approval (i.e., marketed products). These products include therapies in the rare disease space (e.g., transthyretin amyloidosis, porphyria, and other genetic disorders), and the work is conducted in the biopharmaceutical industry, specifically in the area of Health Economics and Outcomes Research (HEOR). Conduct Real-World Evidence (RWE) Analyses. Design and execute real-world data studies using large-scale healthcare databases (e.g., Medicare, Optum Clinformatics, Truven MarketScan, Truveta electronic health records). Develop protocols and statistical analysis plans and write and QC computer programs (e.g., SAS, Snowflake) to analyze treatment patterns, healthcare resource use, medication adherence and persistency, patient survival outcomes, and economic burden of disease. Apply advanced statistical methods such as network meta-analysis and quantitative bias adjustment techniques to conduct indirect treatment comparisons. Develop Payer-Facing Models and Tools. Build economic models and budget impact tools that simulate costs and outcomes associated with the use of the company's therapies compared to standard of care. These tools are used by payer organizations and health technology assessment bodies for coverage and reimbursement decisions. Contribute to Publications and Scientific Communications. Draft abstracts, manuscripts, and conference posters to disseminate study findings. Ensure scientific rigor and compliance with regulatory and ethical standards. Collaborate with cross-functional colleagues. Work with cross-functional stakeholders (including Epidemiologists, Biostatisticians, Medical Affairs, and Market Access teams) to generate evidence that supports the product’s value proposition to payers and regulatory agencies. Supervisory Responsibility. The position does not supervise other employees and does not involve assigning work to subordinates. However, the role may mentor junior team members or collaborate with external vendors (e.g., data analytics firms or contract research organizations) without formal supervisory responsibilities. 100% telecommuting role. Reports to company headquarters in Cambridge, MA. Can work remotely or telecommute.
Qualifications:
Master’s degree in Pharmacy, Economics, Biostatistics, epidemiology, or related field of study and six (6) years of work experience in the job offered or related occupation in which the required experience was gained. In lieu of a Master’s degree in Pharmacy, Economics, Biostatistics, epidemiology, or related field of study and six (6) years of work experience in the job offered or related occupation in which the required experience was gained, employer will also accept a PhD in Pharmacy, Economics, Biostatistics, epidemiology, or related field of study and four (4) years of work experience in the job offered or related occupation in which the required experience was gained.
Must also have demonstrated experience in the following: BI content promotion and project support, administrating, supporting, troubleshooting, installing, configuring, and programming SAS; Working with BI tools and Data Integration; SAS applications installation and project migration; Windows and UNIX Servers in supporting SAS users; Real-world healthcare database research; Synthesizing multiple healthcare data sets to generate new insights in evidence to support commercial objectives; Statistical modelling of observational healthcare data sets; and SAS programming.
|
To Apply: |
To apply, submit resume to: https://jobs.alnylam.com/careers, or submit a resume to: https://jobquest.dcs.eol.mass.gov/jobquest/LandingPage.aspx, or mail resume to: Alnylam US, Inc., Attn: HR, 675 West Kendall Street, Cambridge, MA 02142. Must Reference Job Title: & Code: 000155. EOE. |
SILENCE DISEASE. AMPLIFY LIFE.™
Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them.
Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases.
We are a global and diverse company of 2,600+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-25), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and Great Place to Work.
We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America.
See our social media community guidelines: https://bit.ly/2FcRhJy.
Please note: If you wish to report an adverse event or product complaint, please email [email protected] or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861
Fraudulent Recruitment Activity
Be aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."
Founded
2002
Company size
1,001-5,000 employees
Industry
Biotechnology Research
Org type
Public Company
Headquarters
Cambridge, Massachusetts
SILENCE DISEASE. AMPLIFY LIFE.™
Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them.
Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases.
We are a global and diverse company of 2,600+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-25), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and Great Place to Work.
We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America.
See our social media community guidelines: https://bit.ly/2FcRhJy.
Please note: If you wish to report an adverse event or product complaint, please email [email protected] or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861
Fraudulent Recruitment Activity
Be aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."
Founded
2002
Company size
1,001-5,000 employees
Industry
Biotechnology Research
Org type
Public Company
Headquarters
Cambridge, Massachusetts